Studies suggest that the VEGF/VEGFR-2 pathway may be particularly relevant, as its activation seems to trigger intracellular signaling cascades that potentially influence endothelial cell migration, proliferation, and survival
B12 is also known by the name Cobalamin so don't get confused if you see that term thrown around online
Simple cycle review framework Review point Baseline What to check Research goal, measurements, route, and materials Reason Creates a clear starting point Review point Week 4 What to check Tolerance, handling, and protocol consistency Reason Finds early problems Review point Week 8 What to check Trend compared with baseline Reason Tests whether the plan is producing useful data Review point Week 12 What to check Full review of benefits, limits, and uncertainty Reason Prevents an automatic extension Review point Week 16 or later What to check Reason for continuing and remaining evidence gaps Reason Longer subcutaneous timelines are not clinically established When a Longer Cycle Is Not Supported There is no published evidence showing that extending AOD-9604 beyond 12 or 16 weeks improves the outcome of a community subcutaneous plan
Read across from your vial size, down from your chosen water volume, and the cell gives the resulting concentration
Don't have time to book a clinic appointment
Speaking from my own personal experience, in which pain subsided after no more than two weeks of injections, I wouldn't imagine you'd need to repeat this cycle unless you re-injured yourself